0001485003-16-000133.txt : 20160712
0001485003-16-000133.hdr.sgml : 20160712
20160712163346
ACCESSION NUMBER: 0001485003-16-000133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160709
FILED AS OF DATE: 20160712
DATE AS OF CHANGE: 20160712
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tubridy Karen L
CENTRAL INDEX KEY: 0001589888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161764232
MAIL ADDRESS:
STREET 1: ELEVEN BIOTHERAPEUTICS, INC.
STREET 2: 215 FIRST STREET, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_146835561327274.xml
FORM 4
X0306
4
2016-07-09
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001589888
Tubridy Karen L
C/O ELEVEN BIOTHERAPEUTICS, INC.,
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
0
1
0
0
Chief Development Officer
Stock Option (Right to Buy)
0.28
2016-07-09
4
A
0
13328
0
A
2016-07-09
2026-02-24
Common Stock
13328.0
26672
D
On February 25, 2016, the reporting person was granted an option to purchase 40,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 13,328 shares.The option had previously vested with respect to 13,344 shares.
/s/ John J. McCabe as attorney-in-fact
2016-07-12